136 related articles for article (PubMed ID: 32682840)
21. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.
Tan EK; Kwok HH; Tan LC; Zhao WT; Prakash KM; Au WL; Pavanni R; Ng YY; Satake W; Zhao Y; Toda T; Liu JJ
Neurology; 2010 Aug; 75(6):508-12. PubMed ID: 20697102
[TBL] [Abstract][Full Text] [Related]
22. Common variants of LRRK2 are not associated with sporadic Parkinson's disease.
Biskup S; Mueller JC; Sharma M; Lichtner P; Zimprich A; Berg D; Wüllner U; Illig T; Meitinger T; Gasser T
Ann Neurol; 2005 Dec; 58(6):905-8. PubMed ID: 16254973
[TBL] [Abstract][Full Text] [Related]
23. Fine-mapping of the non-coding variation driving the Caucasian LRRK2 GWAS signal in Parkinson's disease.
Heckman MG; Labbé C; Kolicheski AL; Soto-Beasley AI; Walton RL; Valentino RR; Brennan ER; Johnson PW; Baheti S; Sarangi V; Ren Y; Uitti RJ; Wszolek ZK; Ross OA
Parkinsonism Relat Disord; 2021 Feb; 83():22-30. PubMed ID: 33454605
[TBL] [Abstract][Full Text] [Related]
24. Association between PARK16 and Parkinson's disease in the Han Chinese population: a meta-analysis.
Chang KH; Chen CM; Chen YC; Lyu RK; Chang HS; Ro LS; Lee-Chen GJ; Wu YR
Neurobiol Aging; 2013 Oct; 34(10):2442.e5-9. PubMed ID: 23747047
[TBL] [Abstract][Full Text] [Related]
25. Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.
Agalliu I; Ortega RA; Luciano MS; Mirelman A; Pont-Sunyer C; Brockmann K; Vilas D; Tolosa E; Berg D; Warø B; Glickman A; Raymond D; Inzelberg R; Ruiz-Martinez J; Mondragon E; Friedman E; Hassin-Baer S; Alcalay RN; Mejia-Santana H; Aasly J; Foroud T; Marder K; Giladi N; Bressman S; Saunders-Pullman R
Mov Disord; 2019 Sep; 34(9):1392-1398. PubMed ID: 31348549
[TBL] [Abstract][Full Text] [Related]
26. The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson's disease: a cross-sectional PET study.
Liu SY; Wile DJ; Fu JF; Valerio J; Shahinfard E; McCormick S; Mabrouk R; Vafai N; McKenzie J; Neilson N; Perez-Soriano A; Arena JE; Cherkasova M; Chan P; Zhang J; Zabetian CP; Aasly JO; Wszolek ZK; McKeown MJ; Adam MJ; Ruth TJ; Schulzer M; Sossi V; Stoessl AJ
Lancet Neurol; 2018 Apr; 17(4):309-316. PubMed ID: 29456161
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of LRRK2 A419V variant in ethnic Chinese.
Li NN; Tan EK; Chang XL; Mao XY; Zhang JH; Zhao DM; Liao Q; Peng R
Neurobiol Aging; 2012 Aug; 33(8):1849.e1-3. PubMed ID: 22418733
[TBL] [Abstract][Full Text] [Related]
28. An association between the PARK16 locus and Parkinson's disease in a cohort from eastern China.
Yan YP; Mo XY; Tian J; Zhao GH; Yin XZ; Jin FY; Zhang BR
Parkinsonism Relat Disord; 2011 Dec; 17(10):737-9. PubMed ID: 21840748
[TBL] [Abstract][Full Text] [Related]
29. LRRK2 R1628P contributes to Parkinson's disease susceptibility in Chinese Han populations from mainland China.
Yu L; Hu F; Zou X; Jiang Y; Liu Y; He X; Xi J; Liu L; Liu Z; He L; Xu Y
Brain Res; 2009 Nov; 1296():113-6. PubMed ID: 19699188
[TBL] [Abstract][Full Text] [Related]
30. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide association study of Parkinson's disease in East Asians.
Foo JN; Tan LC; Irwan ID; Au WL; Low HQ; Prakash KM; Ahmad-Annuar A; Bei J; Chan AY; Chen CM; Chen YC; Chung SJ; Deng H; Lim SY; Mok V; Pang H; Pei Z; Peng R; Shang HF; Song K; Tan AH; Wu YR; Aung T; Cheng CY; Chew FT; Chew SH; Chong SA; Ebstein RP; Lee J; Saw SM; Seow A; Subramaniam M; Tai ES; Vithana EN; Wong TY; Heng KK; Meah WY; Khor CC; Liu H; Zhang F; Liu J; Tan EK
Hum Mol Genet; 2017 Jan; 26(1):226-232. PubMed ID: 28011712
[TBL] [Abstract][Full Text] [Related]
32. Association analysis of PARK16-18 variants and Parkinson's disease in a Chinese population.
Zhou LL; Zhang X; Bao QQ; Liu RP; Gong MY; Mao GY; Zou M; Zhu JH
J Clin Neurosci; 2014 Jun; 21(6):1029-32. PubMed ID: 24373818
[TBL] [Abstract][Full Text] [Related]
33. The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease.
Li C; Ting Z; Qin X; Ying W; Li B; Guo Qiang L; Jian Fang M; Jing Z; Jian Qing D; Sheng Di C
Mov Disord; 2007 Dec; 22(16):2439-43. PubMed ID: 17960808
[TBL] [Abstract][Full Text] [Related]
34. PARK16 polymorphisms, interaction with smoking, and sporadic Parkinson's disease in Japan.
Miyake Y; Tanaka K; Fukushima W; Kiyohara C; Sasaki S; Tsuboi Y; Oeda T; Shimada H; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M; Nakamura Y;
J Neurol Sci; 2016 Mar; 362():47-52. PubMed ID: 26944116
[TBL] [Abstract][Full Text] [Related]
35. Olfactory Dysfunction in Parkinson's Disease Patients with the LRRK2 G2385R Variant.
Cao M; Gu ZQ; Li Y; Zhang H; Dan XJ; Cen SS; Li DW; Chan P
Neurosci Bull; 2016 Dec; 32(6):572-576. PubMed ID: 27699718
[TBL] [Abstract][Full Text] [Related]
36. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
37. Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.
Pihlstrøm L; Rengmark A; Bjørnarå KA; Dizdar N; Fardell C; Forsgren L; Holmberg B; Larsen JP; Linder J; Nissbrandt H; Tysnes OB; Dietrichs E; Toft M
J Hum Genet; 2015 Jul; 60(7):357-62. PubMed ID: 25855069
[TBL] [Abstract][Full Text] [Related]
38. Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids.
Kim H; Park HJ; Choi H; Chang Y; Park H; Shin J; Kim J; Lengner CJ; Lee YK; Kim J
Stem Cell Reports; 2019 Mar; 12(3):518-531. PubMed ID: 30799274
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
[TBL] [Abstract][Full Text] [Related]
40. LRRK2-associated Parkinson's disease patients have better stereopsis than idiopathic Parkinson disease.
Sun L; Chan P
Clin Neurol Neurosurg; 2018 Jun; 169():174-177. PubMed ID: 29705653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
